COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.
Autores da FMUP
Participantes de fora da FMUP
- Amaral, L
- Castro, E
- Coimbra, A
- Placido, JL
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Airborne food and aeroallergens levels in healthcare settings. An unaccounted but potentially relevant source of exposure?
Investigador Principal: André Miguel Afonso de Sousa Moreira
Estudo Clínico Académico (Aeroallergens) . 2020
Eosinophil cationic protein (ECP) correlates with eosinophil cell counts in the induced sputum of elite swimmers
Investigador Principal: André Miguel Afonso de Sousa Moreira
Estudo Clínico Académico (ECP) . 2021
How exercise, physical activity and diet modulate immune and stress responses
Investigador Principal: André Miguel Afonso de Sousa Moreira
Estudo Clínico Académico . 2020
Citar a publicação
Rama TA,Miranda J,Silva D,Amaral L,Castro E,Coimbra A,Moreira A,Placido JL. COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication. Vaccines. 2022. 10. (5):p. 718-718. IF:7,800. (1).